Years of life lost due to cancer in the United Kingdom from 1988 to 2017

Br J Cancer. 2023 Nov;129(10):1558-1568. doi: 10.1038/s41416-023-02422-8. Epub 2023 Sep 19.

Abstract

Background: We investigated the application of years of life lost (YLL) in routine cancer statistics using cancer mortality data from 1988 to 2017.

Methods: Cancer mortality data for 17 cancers and all cancers in the UK from 1988 to 2017 were provided by the UK Association of Cancer Registries by sex, 5-year age group, and year. YLL, age-standardised YLL rate (ASYR) and age-standardised mortality rate (ASMR) were estimated.

Results: The annual average YLL due to cancer, in the time periods 1988-1992 and 2013-2017, were about 2.2 and 2.3 million years, corresponding to 4510 and 3823 ASYR per 100,000 years, respectively. During 2013-2017, the largest number of YLL occurred in lung, bowel and breast cancer. YLL by age groups for all cancers showed a peak between 60-64 and 75-79. The relative contributions to incidence, mortality, and YLL differ between cancers. For instance, pancreas (in women and men) made up a smaller proportion of incidence (3%) but bigger proportion of mortality (6 and 5%) and YLL (5 and 6%), whereas prostate cancer (26% of incidence) contributed 13% mortality and 9% YLL.

Conclusion: YLL is a useful measure of the impact different cancers have on society and puts a higher weight on cancer deaths in younger individuals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms* / epidemiology
  • Humans
  • Life Expectancy
  • Male
  • Prostatic Neoplasms*
  • Registries
  • United Kingdom / epidemiology